Results 181 to 190 of about 179,948 (273)

ENLIGHTENme: Translating the Benefits of Self‐Administered Daytime Light Supplementation to Older Adults in the Real World

Journal of Pineal Research, Volume 78, Issue 5, September 2026.
ABSTRACT Controlled studies have demonstrated that light supplementation benefits circadian entrainment, sleep and mood. Translating these findings into effective, real‐world usage of light supplementation is, however, challenging because naturalistic and supplemental light exposure are shaped by personal habits and environmental light conditions ...
Débora B. Constantino, Flavia Baccari, Leonardo Caporali, Valerio Carelli, Giulia Amore, Marijke Gordijn, Toomas Haller, Chiara La Morgia, Anne Landvreugd, Marina Marinelli, David McDaid, Monika Nõmm, Francesco Nonino, Martina Romagnoli, Martino Schettino, Corrado Zenesini, Meike Bartels, Debra J. Skene, Daan R. van der Veen   +18 more
wiley   +1 more source

Comprehensive profiling of gut microbiota in postmenopausal osteoporosis. [PDF]

Turk J Med Sci
Ertürk Çelik G, Yildiz S, Aksoy Bektaş M, Engin Üstün Y.   +3 more
europepmc   +1 more source

Precision or Paradox? AI‐Driven Adiposity Imaging in Women With Overweight and Obesity: A Systematic Review and Meta‐Analysis

Obesity Reviews, Volume 27, Issue 9, September 2026.
ABSTRACT Artificial intelligence (AI) enables automated, high‐throughput adiposity quantification, offering refined risk stratification for women with overweight and obesity. We systematically reviewed and meta‐analyzed studies evaluating AI‐based segmentation of visceral, subcutaneous, and total fat in adult women populations (BMI: 25–29.9 and ≥ 30 kg/
Asefa Adimasu Taddese, Bjorn T. Tam
wiley   +1 more source

Visual analysis of the literature on postmenopausal osteoporosis-related hormone research: Current status and future trends (2004-2024). [PDF]

Medicine (Baltimore)
Li Y, Jin B, Li K, Zou S, Meng L.
europepmc   +1 more source

Breaking the Debilitating Cycle: Pathophysiology, Assessment, and Multimodal Intervention of Secondary Debilitation After Hip Fracture in Older Adults—A Narrative Review

Orthopaedic Surgery, Volume 18, Issue 9, Page 1785-1803, September 2026.
This article provides a comprehensive overview of the pathophysiological mechanisms underlying “secondary debilitation after hip fracture,” discusses the clinical application of risk assessment tools, and presents a phased, stepwise intervention strategy aimed at interrupting the “vicious cycle.” ABSTRACT Hip fractures pose a serious threat to the ...
Wenyang Xu, Fan Xu, Maoqiang Fan, Yao Liu, Zhe Song   +4 more
wiley   +1 more source

Ubiquitin-proteasome system regulation of bone remodeling in postmenopausal osteoporosis. [PDF]

Front Cell Dev Biol
Chen X, Zhao T, Zhou H, Zeng Q, Xu H, Dai Y, Yan M.   +6 more
europepmc   +1 more source

Musculoskeletal and physiological responses to vortex wave stimulation in older adults

The Journal of Physiology, Volume 604, Issue 17, Page 7264-7286, 1 September 2026.
Abstract figure legend We explored the acute physiological effects of a novel mechanical stimulus, vortex wave stimulation (VWS), in healthy older adults. Using deuterated water and serial skeletal muscle biopsies, we showed that VWS elevated integrated rates of myofibrillar, but not sarcoplasmic muscle protein synthesis, with no changes observed in ...
Alexander Waddell, Marie Korzepa, Archie E. Belfield, Ben Fry, Rickson C Mesquita, David Smith, Jonathan Quinlan, Leigh Breen   +7 more
wiley   +1 more source

Neddylation of NFATc1 and Runx2 regulates osteoclast-osteoblast balance and represents a dual-action therapeutic target for postmenopausal osteoporosis. [PDF]

Exp Mol Med
Lee J, Lee MY, Kim HS, Park JW, Moon GH, Park JB, Kim HJ, Kim SJ, Chun YS.   +8 more
europepmc   +1 more source

A Cross-Tissue Multiomics Analysis Reveals the Protective Role of TGFBR3 in Postmenopausal Osteoporosis. [PDF]

Int J Genomics
Liu Y, Xie C, Yang K, Liu Z, Liu R, Hou X, Xing L, Gao J, Lian Q, Hu Y, Wang Y, Zhang L, Tian F.   +12 more
europepmc   +1 more source

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis. [PDF]

Pharmacoecon Open
Flanigan J, Kane S, Mirzayeh Fashami F, Zhou A, Almuallem L, Tindal M, Schauf M, Li E, Lyman GH.   +8 more
europepmc   +1 more source